Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E.
Sci Rep. 2022 May 3;12(1):7140.
doi: 10.1038/s41598-022-10777-w. PMID: 35504889 Free PMC article.